HKU Scholars Hub: Browsing DSpace

Browsing by Author Crown, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 3 of 3

	Title	Author(s)	Issue Date	Views
	Adjuvant Trastuzumab in HER2-Positive Breast Cancer Journal:New England Journal of Medicine	Slamon, D Eiermann, W Robert, N Pienkowski, T Martin, M Press, M Mackey, J Glaspy, J Chan, A Pawlicki, M Pinter, T Valero, V Liu, EC Sauter, G von Minckwitz, G Visco, F Bee, V Buyse, M Bendahmane, B Tabah-Fisch, I Lindsay, MA Riva, A Crown, J Breast Cancer International Research Group Kwong, A	2011	283
	Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study Journal:The Lancet Oncology	Martin, M Roche, H Pinter, T Crown, J Kennedy, MJ Provencher, L Priou, F Eiermann, W Adrover, E Lang, I Ramos, M Latreille, J Jagiełło-Gruszfeld, A Pienkowski, T Alba, E Snyder, R Almel, S Rolski, J Munoz, M Moroose, R Hurvitz, S Baños, A Adewoye, H Hei, YJ Lindsay, MA Rupin, M Cabaribere, D Lemmerick, Y Mackey, JR Kwong, A	2011	60
	Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial Journal:Journal of Clinical Oncology	Saura, C Oliveira, M Feng, YH Dai, MS Chen, SW Hurvitz, SA Kim, SB Moy, B Delaloge, S Gradishar, W Masuda, N Palacova, M Trudeau, ME Mattson, J Yap, YS V, MF De Laurentiis, M Yeh, YM Chang, HT Yau, T Wildiers, H Haley, B Fagnani, D Lu, YS Crown, J Lin, J Takahashi, M Takano, T Yamaguchi, M Fujii, T Yao, B Bebchuk, J Keyvanjah, K Bryce, R Brufsky, A The NALA Investigators	2020	35

Showing results 1 to 3 of 3